EE200300340A - (R)-ibuprofeenmetaansulfoonamiidi või selle soolakasutamine ravimite valmistamiseks, mis on ette nähtud siiratud elundite isheemia/reperfusiooni kahjustuse ärahoidmiseks või raviks - Google Patents
(R)-ibuprofeenmetaansulfoonamiidi või selle soolakasutamine ravimite valmistamiseks, mis on ette nähtud siiratud elundite isheemia/reperfusiooni kahjustuse ärahoidmiseks või raviksInfo
- Publication number
- EE200300340A EE200300340A EEP200300340A EEP200300340A EE200300340A EE 200300340 A EE200300340 A EE 200300340A EE P200300340 A EEP200300340 A EE P200300340A EE P200300340 A EEP200300340 A EE P200300340A EE 200300340 A EE200300340 A EE 200300340A
- Authority
- EE
- Estonia
- Prior art keywords
- prevention
- treatment
- salt
- ischemia
- medicament
- Prior art date
Links
- URZONQSEPBBTSB-HNCPQSOCSA-N methanesulfonamide;(2r)-2-[4-(2-methylpropyl)phenyl]propanoic acid Chemical compound CS(N)(=O)=O.CC(C)CC1=CC=C([C@@H](C)C(O)=O)C=C1 URZONQSEPBBTSB-HNCPQSOCSA-N 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- 210000000056 organ Anatomy 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title abstract 2
- 206010063837 Reperfusion injury Diseases 0.000 title 1
- 208000028867 ischemia Diseases 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000006243 chemical reaction Methods 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 208000014674 injury Diseases 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Transplantation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001MI000206A ITMI20010206A1 (it) | 2001-02-02 | 2001-02-02 | Uso della metansolfonammide di (r)-ibuprofene e dei suoi sali non tossici per la preparazione di medicamenti per il trattamento e la prevenz |
| PCT/EP2002/000946 WO2002062330A2 (en) | 2001-02-02 | 2002-01-30 | Use of (r)-ibuprofen methanesulfonamide and salts thereof in the treatment and prevention of rejection reactions of transplanted organs |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200300340A true EE200300340A (et) | 2003-10-15 |
| EE05233B1 EE05233B1 (et) | 2009-12-15 |
Family
ID=11446717
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200300340A EE05233B1 (et) | 2001-02-02 | 2002-01-30 | (R)-ibuprofeenmetaansulfoonamiidi v?i selle soola kasutamine ravimite valmistamiseks, mis on ette nhtud siiratud elundite isheemia/reperfusiooni kahjustuse rahoidmiseks v?i raviks |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US7560487B2 (et) |
| EP (1) | EP1355641B1 (et) |
| JP (1) | JP2004517948A (et) |
| KR (1) | KR100857898B1 (et) |
| CN (1) | CN1561205A (et) |
| AT (1) | ATE304846T1 (et) |
| AU (1) | AU2002250869B2 (et) |
| BR (2) | BRPI0206804B1 (et) |
| CA (1) | CA2432432C (et) |
| CZ (1) | CZ303665B6 (et) |
| DE (1) | DE60206245T2 (et) |
| DK (1) | DK1355641T3 (et) |
| EE (1) | EE05233B1 (et) |
| ES (1) | ES2248541T3 (et) |
| HU (1) | HU229070B1 (et) |
| IL (1) | IL157180A (et) |
| IT (1) | ITMI20010206A1 (et) |
| MX (1) | MXPA03006686A (et) |
| NO (1) | NO334285B1 (et) |
| NZ (1) | NZ526655A (et) |
| PL (1) | PL215109B1 (et) |
| PT (1) | PT1355641E (et) |
| RU (1) | RU2257895C2 (et) |
| SK (1) | SK287632B6 (et) |
| WO (1) | WO2002062330A2 (et) |
| ZA (1) | ZA200304861B (et) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2279248T3 (es) * | 2004-03-25 | 2007-08-16 | Dompe' Pha.R.Ma S.P.A. | Uso de n-(2-aril-propionil)-sulfonamidas para el tratamiento de lesiones de la medula espinal. |
| JP2008545627A (ja) | 2005-05-09 | 2008-12-18 | タツプ・フアーマシユーテイカル・プロダクツ・インコーポレイテツド | 腎結石症を治療する方法 |
| CA2669935A1 (en) * | 2006-11-13 | 2008-05-29 | Takeda Pharmaceuticals North America, Inc. | Methods for preserving renal function using xanthine oxidoreductase inhibitors |
| EP2308484A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Inhibitors of cxcr1/2 as adjuvants in the transplant of pancreatic islets |
| EP2308485A1 (en) * | 2009-10-06 | 2011-04-13 | Dompé S.p.a. | Sulfonamides for the prevention of diabetes |
| CA2812034C (en) | 2010-09-10 | 2018-10-23 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for concomitant treatment of theophylline and febuxostat |
| US10046002B2 (en) | 2013-08-02 | 2018-08-14 | Syntrix Biosystems Inc. | Method for treating cancer using chemokine antagonists |
| US10561676B2 (en) * | 2013-08-02 | 2020-02-18 | Syntrix Biosystems Inc. | Method for treating cancer using dual antagonists of CXCR1 and CXCR2 |
| EP3596476B1 (en) * | 2017-03-15 | 2024-01-10 | Numares AG | Use of a marker set for determining the risk of kidney rejection |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879283A (en) * | 1985-10-03 | 1989-11-07 | Wisconsin Alumni Research Foundation | Solution for the preservation of organs |
| JPH08231413A (ja) * | 1994-12-29 | 1996-09-10 | Mochida Pharmaceut Co Ltd | 臓器障害に基づく疾患の予防・治療剤 |
| IT1303249B1 (it) * | 1998-10-23 | 2000-11-06 | Dompe Spa | Alcune n-(2-aril-propionil)-solfonammidi e preparazionifarmaceutiche che le contengono. |
| US6355682B1 (en) * | 2001-05-11 | 2002-03-12 | Assa Weinberg | Treatment of acute renal failure by administration of N-acetylcysteine |
-
2001
- 2001-02-02 IT IT2001MI000206A patent/ITMI20010206A1/it unknown
-
2002
- 2002-01-30 AT AT02719742T patent/ATE304846T1/de active
- 2002-01-30 EP EP02719742A patent/EP1355641B1/en not_active Expired - Lifetime
- 2002-01-30 BR BRPI0206804A patent/BRPI0206804B1/pt unknown
- 2002-01-30 DK DK02719742T patent/DK1355641T3/da active
- 2002-01-30 JP JP2002562337A patent/JP2004517948A/ja active Pending
- 2002-01-30 PT PT02719742T patent/PT1355641E/pt unknown
- 2002-01-30 CZ CZ20032095A patent/CZ303665B6/cs not_active IP Right Cessation
- 2002-01-30 PL PL363576A patent/PL215109B1/pl unknown
- 2002-01-30 CN CNA028042263A patent/CN1561205A/zh active Pending
- 2002-01-30 WO PCT/EP2002/000946 patent/WO2002062330A2/en active IP Right Grant
- 2002-01-30 SK SK973-2003A patent/SK287632B6/sk not_active IP Right Cessation
- 2002-01-30 EE EEP200300340A patent/EE05233B1/et not_active IP Right Cessation
- 2002-01-30 AU AU2002250869A patent/AU2002250869B2/en not_active Ceased
- 2002-01-30 DE DE60206245T patent/DE60206245T2/de not_active Expired - Lifetime
- 2002-01-30 BR BR0206804-4A patent/BR0206804A/pt not_active IP Right Cessation
- 2002-01-30 MX MXPA03006686A patent/MXPA03006686A/es active IP Right Grant
- 2002-01-30 RU RU2003126600/15A patent/RU2257895C2/ru not_active IP Right Cessation
- 2002-01-30 HU HU0303024A patent/HU229070B1/hu not_active IP Right Cessation
- 2002-01-30 ES ES02719742T patent/ES2248541T3/es not_active Expired - Lifetime
- 2002-01-30 KR KR1020037009714A patent/KR100857898B1/ko active IP Right Grant
- 2002-01-30 CA CA002432432A patent/CA2432432C/en not_active Expired - Fee Related
- 2002-01-30 NZ NZ526655A patent/NZ526655A/en not_active IP Right Cessation
-
2003
- 2003-01-30 US US10/250,465 patent/US7560487B2/en not_active Expired - Fee Related
- 2003-06-23 ZA ZA200304861A patent/ZA200304861B/en unknown
- 2003-07-18 NO NO20033273A patent/NO334285B1/no not_active IP Right Cessation
- 2003-07-31 IL IL157180A patent/IL157180A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE517624T1 (de) | Behandlung von neurodegenerativen erkrankungen und krebs im gehirn | |
| EE02971B1 (et) | Droloksüfeeni või selle soolade kasutamine luuhaiguste vastase ravimi valmistamiseks | |
| BG106825A (en) | Substituted oxazolidinones and their use in the field of blood coagulation | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| DE60118604D1 (de) | Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen | |
| CA2436462A1 (en) | Inhibitors of cruzipain and other cysteine proteases | |
| EE200300340A (et) | (R)-ibuprofeenmetaansulfoonamiidi või selle soolakasutamine ravimite valmistamiseks, mis on ette nähtud siiratud elundite isheemia/reperfusiooni kahjustuse ärahoidmiseks või raviks | |
| ATE407675T1 (de) | Aspirin enthaltende medizinische zusammensetzungen | |
| EP1197210A4 (en) | MEANS TO PREVENT THE CHRONIC BREATHING REACTION AS A RESULT OF AN ORGANTRANSPLANTATION | |
| DE60128100D1 (de) | Analgetisches arzneimittel | |
| TR200200473T2 (tr) | Rar selektif retinoid agonistleri. | |
| BR0313655A (pt) | Uso de n-(3-metóxi-5-metilpirazin-2-il)-2-(4-[1, 3, 4-oxadiazol-2-il]fenil) piridina-3-sulfonamida, ou um sal do mesmo farmaceuticamente aceitável | |
| JP2004517948A5 (et) | ||
| DE602004022783D1 (de) | Heterozyklische harnstoff-derivate für die behandlung von schmerzen. | |
| SE0300535D0 (sv) | Treatment of burns | |
| RU2004119059A (ru) | Препарат для лечения и профилактики эндометритов у коров - "альгацин" | |
| DK1755583T3 (da) | Anvendelse af neboglamin til behandling af skizofreni | |
| PL1514545T3 (pl) | Zastosowanie tolperyzonu do leczenia skurczów narządów zbudowanych zasadniczo z mięśni gładkich | |
| RU2006104187A (ru) | Препарат для лечения микозов и гнойной инфекции | |
| EA200501765A2 (ru) | Средство для лечения болезней суставов | |
| TH57870B (th) | การใช้แบบใหม่ของสารประกอบในฐานะสารต้านแบคทีเรีย | |
| TH67520A (th) | การรักษาหน้าที่เนื้อเยื่อปลูกถ่ายที่ช้า | |
| RU2003117875A (ru) | Фармацевтическая композиция для лечения воспалительных процессов заднего отрезка глаза "кселипос" | |
| TH77070B (th) | สารผสมทางเภสัชกรรมสำหรับการรักษาอาการโรคของทางเดินปัสสาวะส่วนล่าง |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB1A | Change in the ownership or in the address of the owner | ||
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| GB1A | Change in the ownership or in the address of the owner | ||
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20200130 |